Logo image of CETX

CEMTREX INC (CETX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CETX - US15130G8731 - Common Stock

2.28 USD
-0.15 (-6.17%)
Last: 12/26/2025, 8:00:00 PM
2.24 USD
-0.04 (-1.75%)
After Hours: 12/26/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, CETX scores 3 out of 10 in our fundamental rating. CETX was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. CETX may be in some trouble as it scores bad on both profitability and health. CETX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CETX had negative earnings in the past year.
CETX had a positive operating cash flow in the past year.
In the past 5 years CETX always reported negative net income.
CETX had a negative operating cash flow in each of the past 5 years.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

CETX has a Return On Assets of -43.62%. This is amonst the worse of the industry: CETX underperforms 80.65% of its industry peers.
With a Return On Equity value of -566.16%, CETX is not doing good in the industry: 95.16% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 6.61%, CETX is in the better half of the industry, outperforming 68.55% of the companies in the same industry.
Industry RankSector Rank
ROA -43.62%
ROE -566.16%
ROIC 6.61%
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 2.50%, CETX is in line with its industry, outperforming 52.42% of the companies in the same industry.
Looking at the Gross Margin, with a value of 43.13%, CETX is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
CETX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.5%
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CETX is still creating some value.
The number of shares outstanding for CETX has been reduced compared to 1 year ago.
Compared to 5 years ago, CETX has more shares outstanding
CETX has a better debt/assets ratio than last year.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500 1K 1.5K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CETX has an Altman-Z score of -0.97. This is a bad value and indicates that CETX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CETX (-0.97) is worse than 81.45% of its industry peers.
A Debt/Equity ratio of 2.40 is on the high side and indicates that CETX has dependencies on debt financing.
CETX's Debt to Equity ratio of 2.40 is on the low side compared to the rest of the industry. CETX is outperformed by 94.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF N/A
Altman-Z -0.97
ROIC/WACC1.65
WACC4.01%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

CETX has a Current Ratio of 1.20. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
CETX has a Current ratio of 1.20. This is amonst the worse of the industry: CETX underperforms 86.29% of its industry peers.
CETX has a Quick Ratio of 1.20. This is a bad value and indicates that CETX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CETX (0.96) is worse than 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.96
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. Growth

3.1 Past

CETX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.48%, which is quite impressive.
The Revenue has grown by 16.50% in the past year. This is quite good.
Measured over the past years, CETX shows a quite strong growth in Revenue. The Revenue has been growing by 11.21% on average per year.
EPS 1Y (TTM)98.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.7%
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%15.49%

3.2 Future

CETX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 89.28% yearly.
CETX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.00% yearly.
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 2M -2M 4M -4M -6M

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 1.11, which indicates a rather cheap valuation of CETX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CETX indicates a rather cheap valuation: CETX is cheaper than 99.19% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, CETX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.11
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

CETX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CETX is cheaper than 97.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.73
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100 -150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CETX's earnings are expected to grow with 89.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.28%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CETX!.
Industry RankSector Rank
Dividend Yield 0%

CEMTREX INC

NASDAQ:CETX (12/26/2025, 8:00:00 PM)

After market: 2.24 -0.04 (-1.75%)

2.28

-0.15 (-6.17%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-12 2025-08-12
Earnings (Next)12-29 2025-12-29/amc
Inst Owners3.4%
Inst Owner Change-71.79%
Ins Owners0%
Ins Owner Change0%
Market Cap1.69M
Revenue(TTM)76.10M
Net Income(TTM)-20.48M
Analysts82.86
Price TargetN/A
Short Float %31.08%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.11
P/S 0.02
P/FCF N/A
P/OCF 1.1
P/B 0.47
P/tB N/A
EV/EBITDA 4.73
EPS(TTM)-168.32
EYN/A
EPS(NY)2.05
Fwd EY89.92%
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)2.08
OCFY91.15%
SpS102.83
BVpS4.89
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.62%
ROE -566.16%
ROCE 8.44%
ROIC 6.61%
ROICexc 9.56%
ROICexgc 12.51%
OM 2.5%
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
F-Score5
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF N/A
Debt/EBITDA 2.72
Cap/Depr 178.45%
Cap/Sales 3.03%
Interest Coverage 0.96
Cash Conversion 48.14%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 0.96
Altman-Z -0.97
F-Score5
WACC4.01%
ROIC/WACC1.65
Cap/Depr(3y)155.23%
Cap/Depr(5y)125.9%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.7%
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%15.49%
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y138.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.35%
OCF growth 3YN/A
OCF growth 5YN/A

CEMTREX INC / CETX FAQ

Can you provide the ChartMill fundamental rating for CEMTREX INC?

ChartMill assigns a fundamental rating of 3 / 10 to CETX.


What is the valuation status of CEMTREX INC (CETX) stock?

ChartMill assigns a valuation rating of 5 / 10 to CEMTREX INC (CETX). This can be considered as Fairly Valued.


What is the profitability of CETX stock?

CEMTREX INC (CETX) has a profitability rating of 2 / 10.


What is the financial health of CEMTREX INC (CETX) stock?

The financial health rating of CEMTREX INC (CETX) is 2 / 10.